# Challenge Programme 2027 – Heat and Hypertension - understanding the mechanisms of interaction

**Funder:** Novo Nordisk Foundation
**Budget:** DKK 30-75 million per grant
**Deadline:** 7 October 2026 (14:00 Copenhagen time)
**Duration:** 6 years
**Consortium:** Required — leading researchers forming a consortium united by a clear vision and mission
**Application:** 2-stage: Stage 1 results December 2026 → Stage 2 results June 2027
**Frequency:** Annual
**Eligible countries:** DK
**Official call:** https://novonordiskfonden.dk/en/grant/challenge-programme-2027-heat-and-hypertension-understanding-the-mechanisms-of-interaction/
**Last updated:** 14 Oct 2026

> **Recently updated:** catalog cleanup 2026-07-04: duplicate row (canonical sibling kept)

## Eligibility & scope

Funds a consortium of leading researchers in Denmark to study the mechanisms of interaction between heat and hypertension, targeting Research Leaders (Established/Professor level) in endocrinology and metabolism, bioscience, and clinical/translational medicine. Host institution must be in Denmark.

## Summary

The Novo Nordisk Foundation Challenge Programme 2027 funds a Danish consortium of senior researchers to study how heat and hypertension interact mechanistically, with grants of DKK 30-75 million over six years. The call targets Research Leaders at Established or Professor level in endocrinology and metabolism, bioscience, or clinical/translational medicine, hosted at a Danish institution. It requires a consortium united by a shared scientific vision rather than a single investigator proposal.

## Who should apply

- Senior Research Leaders at Established or Professor level
- Consortium of researchers in endocrinology and metabolism, bioscience, or clinical/translational medicine
- Host institution must be based in Denmark
- Teams able to unite around a single consortium-wide vision and mission on heat-hypertension interaction

## Key dates

- Application deadline 7 October 2026, 14:00 Copenhagen time
- Two-stage evaluation: Stage 1 results December 2026, Stage 2 results June 2027
- Six-year project duration

## Tips for applicants

- Frame the proposal around a single consortium-wide vision and mission rather than a set of loosely linked sub-projects, reviewers assess coherence across the whole team.
- Stage 1 to Stage 2 spans six months; plan consortium-building and letters of commitment well before the October deadline so the full proposal can be assembled quickly after Stage 1 results.
- Given the mechanistic focus on heat and hypertension, pair endocrine/metabolic expertise with clinical/translational investigators explicitly in the leadership structure.

## Frequently asked questions

### How much does the Novo Nordisk Foundation Challenge Programme 2027 grant pay?

Grants range from DKK 30-75 million (approximately €4-10 million) per award.

### Who can apply for this Challenge Programme?

Research Leaders at Established or Professor level in endocrinology and metabolism, bioscience, or clinical/translational medicine, forming a consortium hosted at a Danish institution.

### How long does the grant last?

The funded project runs for six years.

### Is this a single-stage or multi-stage application?

It is a two-stage process, with Stage 1 results announced in December 2026 and Stage 2 results in June 2027.

### Does this call require a consortium?

Yes, it requires a consortium of leading researchers united by a clear shared vision and mission, rather than a single applicant.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/novo-nordisk-foundation-challenge-programme-2027-heat-and-hypertension-und-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md&grant=novo-nordisk-foundation-challenge-programme-2027-heat-and-hypertension-und-2026).